Misawa, Takeyuki http://orcid.org/0000-0001-8330-359X
Endo, Hideki
Mori, Toshiyuki
Yamaguchi, Shigeki
Inomata, Masafumi
Yamamoto, Hiroyuki
Sakai, Yoshiharu
Kakeji, Yoshihiro
Miyata, Hiroaki
Kitagawa, Yuko
Article History
Received: 23 November 2022
Accepted: 12 February 2023
First Online: 2 March 2023
Declarations
:
: Drs. Hideki Endo and Hiroyuki Yamamoto, who are affiliated with the Department of Healthcare Quality Assessment, Graduate School of Medicine, the University of Tokyo, receive endowments from the National Clinical Database, Johnson & Johnson K.K., and Nipro Corporation. Dr. Hiroyuki Yamamoto has received consulting fees from Mitsubishi Tanabe Pharma Corporation; received honoraria for his lectures from Chugai Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd.; and received payment for writing a manuscript from Astellas Pharma, Inc. Dr. Yuko Kitagawa is affiliated with Keio University School of Medicine, which has received grants from Asahi Kasei Pharma Corporation, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory Inc., Nippon Covidien Inc., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Tsumura & Co., Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Medicon Inc., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Limited. Dr. Yuko Kitagawa has received honoraria from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory Inc., Shionogi & Co., Ltd., Nippon Covidien Inc., Ethicon, Inc., Ono Pharmaceutical Co., Ltd., Olympus Corporation, Bristol-Myers Squibb K.K., AstraZeneca K.K., MSD K.K., Smith & Nephew K.K., Kaken Pharmaceutical Co., Ltd., ASKA Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Toray Industries, Inc., Daiichi Sankyo Company, Limited, Chugai Foundation for Innovative Drug Discovery Science, Nippon Kayaku Co., Ltd., EA Pharma Co., Ltd., Intuitive Surgical G.K., and Takeda Pharmaceutical Co., Ltd. Dr. Hiroaki Miyata has received provision of materials from the National Clinical Database, Johnson & Johnson K.K., Nipro Corporation, and Intuitive Surgical Sàrl. Dr. Masafumi Inomata has received honoraria from Olympus Co. Ltd., Medtronic Co. Ltd., and Johnson & Johnson K.K. Drs. Takeyuki Misawa, Toshiyuki Mori, Shigeki Yamaguchi, Yoshiharu Sakai, and Yoshihiro Kakeji have no conflicts of interest or financial ties to disclose.